Guillain-Barré syndrome reported in few Johnson & Johnson vaccine recipients: What is the rare nerve disorder?
A new warning from the Food and Drug Administration (FDA) over an elevated risk of a rare autoimmune nerve disorder among a small fraction of Johnson & Johnson infectious-disease infectious-diseaserecipients has sparked concern: What is Guillain-Barré syndrome? FDA WARNS ON POTENTIAL JOHNSON & JOHNSON COVID-19 VACCINE LINK TO RARE DISORDER Guillain-Barré syndrome (GBS) occurs when…